Lineage Cell Therapeutics Stock Probability of Future Stock Price Finishing Under 0.88
| LCTX Stock | USD 0.72 0.03 4.35% |
Lineage |
Lineage Cell Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lineage Cell for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lineage Cell Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lineage Cell is way too risky over 90 days horizon | |
| Lineage Cell has some characteristics of a very speculative penny stock | |
| Lineage Cell appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 8.95 M. Net Loss for the year was (21.49 M) with profit before overhead, payroll, taxes, and interest of 11.03 M. | |
| Lineage Cell Therapeutics currently holds about 66.36 M in cash with (28.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.39. |
Lineage Cell Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Lineage Stock often depends not only on the future outlook of the current and potential Lineage Cell's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lineage Cell's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 172.7 M | |
| Cash And Short Term Investments | 35.5 M |
Lineage Cell Technical Analysis
Lineage Cell's future price can be derived by breaking down and analyzing its technical indicators over time. Lineage Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lineage Cell Therapeutics. In general, you should focus on analyzing Lineage Stock price patterns and their correlations with different microeconomic environments and drivers.
Lineage Cell Predictive Forecast Models
Lineage Cell's time-series forecasting models is one of many Lineage Cell's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Lineage Cell's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Lineage Cell Therapeutics
Checking the ongoing alerts about Lineage Cell for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Lineage Cell Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Lineage Cell is way too risky over 90 days horizon | |
| Lineage Cell has some characteristics of a very speculative penny stock | |
| Lineage Cell appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 8.95 M. Net Loss for the year was (21.49 M) with profit before overhead, payroll, taxes, and interest of 11.03 M. | |
| Lineage Cell Therapeutics currently holds about 66.36 M in cash with (28.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.39. |
Additional Tools for Lineage Stock Analysis
When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.